Regulation of p53 stability by Mdm2
- 15 May 1997
- journal article
- research article
- Published by Springer Nature in Nature
- Vol. 387 (6630), 299-303
- https://doi.org/10.1038/387299a0
Abstract
The tumour-suppressor p53 is a short-lived protein that is maintained at low, often undetectable, levels in normal cells. Stabilization of the protein in response to an activating signal, such as DNA damage, results in a rapid rise in p53 levels and subsequent inhibition of cell growth1. Tight regulation of p53 function is critical for normal cell growth and development, and one mechanism by which p53 function is controlled is through interaction with the Mdm2 protein2–4. Mdm2 inhibits p53 cell-cycle arrest and apoptic functions5,6 and we show here that interaction with Mdm2 can also result in a large reduction in p53 protein levels through enhanced proteasome-dependent degradation. Endogenous levels of Mdm2 are sufficient to regulate p53 stability, and overexpres-sion of Mdm2 can reduce the amount of endogenous p53. Because mdm2 is transcriptionally activated by p53 (refs 7, 8), this degradative pathway may contribute to the maintenance of low p53 concentrations in normal cells. Furthermore, mechanisms regulating the Mdm2-induced degradation of p53 may play a role in controlling the extent and duration of the p53 response.Keywords
This publication has 31 references indexed in Scilit:
- Mdm2 promotes the rapid degradation of p53Nature, 1997
- Rescue of embryonic lethality in Mdm2-deficient mice by absence of p53Nature, 1995
- Rescue of early embryonic lethality in mdm2-deficient mice by deletion of p53Nature, 1995
- Stimulation of E2F1/DP1 transcriptional activity by MDM2 oncoproteinNature, 1995
- DNA damage triggers a prolonged p53-dependent G1 arrest and long-term induction of Cip1 in normal human fibroblasts.Genes & Development, 1994
- Several hydrophobic amino acids in the p53 amino-terminal domain are required for transcriptional activation, binding to mdm-2 and the adenovirus 5 E1B 55-kD protein.Genes & Development, 1994
- The p53-mdm-2 autoregulatory feedback loop.Genes & Development, 1993
- Oncoprotein MDM2 conceals the activation domain of tumour suppressor p53Nature, 1993
- The mdm-2 oncogene product forms a complex with the p53 protein and inhibits p53-mediated transactivationCell, 1992
- Expression of RB and p53 proteins in HPV‐positive and HPV‐negative cervical carcinoma cell linesMolecular Carcinogenesis, 1991